Interstitial lung changes and persistent COVID-19 in a patient with follicular lymphoma: A case report.

Autor: Yomota M; Department of Respiratory Medicine Tokyo Metropolitan Komagome Hospital Tokyo Japan., Tanaka M; Department of Infectious Diseases Tokyo Metropolitan Komagome Hospital Tokyo Japan., Kobayashi T; Department of Respiratory Medicine Tokyo Metropolitan Komagome Hospital Tokyo Japan., Kitano M; Department of Respiratory Medicine Tokyo Metropolitan Komagome Hospital Tokyo Japan., Ikeda S; Department of Respiratory Medicine Tokyo Metropolitan Komagome Hospital Tokyo Japan., Kanemasa Y; Department of Oncology Tokyo Metropolitan Komagome Hospital Tokyo Japan., Yanagawa N; Department of Radiology Tokyo Metropolitan Komagome Hospital Tokyo Japan., Hosomi Y; Department of Respiratory Medicine Tokyo Metropolitan Komagome Hospital Tokyo Japan.
Jazyk: angličtina
Zdroj: Respirology case reports [Respirol Case Rep] 2024 Feb 20; Vol. 12 (2), pp. e01298. Date of Electronic Publication: 2024 Feb 20 (Print Publication: 2024).
DOI: 10.1002/rcr2.1298
Abstrakt: We herein report a case of interstitial lung changes in a patient with prolonged coronavirus disease 2019 (COVID-19) with follicular lymphoma receiving rituximab and bendamustine who recovered after treatment with a combination therapy consisting of corticosteroids and immunosuppressive agents. There is currently no treatment strategy for prolonged pneumonitis following COVID-19, which can be life-threatening for immunocompromised patients. Thus, further investigation is warranted.
Competing Interests: Dr. Hosomi reports personal fees from AstraZeneca outside the submitted work; Dr. Yomota, Dr Tanaka, Dr Kobayashi, Dr Kitano, Dr Ikeda, Dr Kanemasa and Dr Yanagawa have nothing to disclose.
(© 2024 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje